BAG2 Antibody (monoclonal) (M01)

O95816

WB

Large-scale mapping of human protein-protein interactions by mass spectrometry. Ewing RM, et al. Mol Syst Biol, 2007. PMID 17353931.The LIFEdb database in 2006. Mehrle A, et al. Nucleic Acids Res, 2006 Jan 1. PMID 16381901.Diversification of transcriptional modulation: large-scale identification and characterization of putative alternative promoters of human genes. Kimura K, et al. Genome Res, 2006 Jan. PMID 16344560.BAG-2 acts as an inhibitor of the chaperone-associated ubiquitin ligase CHIP. Arndt V, et al. Mol Biol Cell, 2005 Dec. PMID 16207813.Regulation of the cytoplasmic quality control protein degradation pathway by BAG2. Dai Q, et al. J Biol Chem, 2005 Nov 18. PMID 16169850.

9532

Mouse monoclonal antibody raised against a partial recombinant BAG2.

Antibody Reactive Against Recombinant Protein.Western Blot detection against Immunogen (37.84 KDa) .

1:500~1000

WB

NM_004282

Human: ~~ Positive

NP_004273.1

NP_004273

BAG proteins compete with Hip for binding to the Hsc70/Hsp70 ATPase domain and promote substrate release. All the BAG proteins have an approximately 45-amino acid BAG domain near the C terminus but differ markedly in their N-terminal regions. The predicted BAG2 protein contains 211 amino acids. The BAG domains of BAG1, BAG2, and BAG3 interact specifically with the Hsc70 ATPase domain in vitro and in mammalian cells. All 3 proteins bind with high affinity to the ATPase domain of Hsc70 and inhibit its chaperone activity in a Hip-repressible manner. [provided by RefSeq